- Home
- BCTX vs ADGM Comparison
BCTX vs ADGM Comparison
Compare BCTX & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCTX
- ADGM
- Stock Information
- Founded
- BCTX 2014
- ADGM 2011
- Country
- BCTX Canada
- ADGM United States
- Employees
- BCTX N/A
- ADGM N/A
- Industry
- BCTX Biotechnology: Pharmaceutical Preparations
- ADGM
- Sector
- BCTX Health Care
- ADGM
- Exchange
- BCTX Nasdaq
- ADGM NYSE
- Market Cap
- BCTX 23.5M
- ADGM 19.7M
- IPO Year
- BCTX N/A
- ADGM N/A
- Fundamental
- Price
- BCTX $3.11
- ADGM $1.23
- Analyst Decision
- BCTX Strong Buy
- ADGM
- Analyst Count
- BCTX 1
- ADGM 0
- Target Price
- BCTX $32.00
- ADGM N/A
- AVG Volume (30 Days)
- BCTX 359.2K
- ADGM 54.2K
- Earning Date
- BCTX 06-16-2025
- ADGM 05-15-2025
- Dividend Yield
- BCTX N/A
- ADGM N/A
- EPS Growth
- BCTX N/A
- ADGM N/A
- EPS
- BCTX N/A
- ADGM N/A
- Revenue
- BCTX N/A
- ADGM $576,000.00
- Revenue This Year
- BCTX N/A
- ADGM N/A
- Revenue Next Year
- BCTX N/A
- ADGM N/A
- P/E Ratio
- BCTX N/A
- ADGM N/A
- Revenue Growth
- BCTX N/A
- ADGM 116.54
- 52 Week Low
- BCTX $2.78
- ADGM $0.63
- 52 Week High
- BCTX $29.40
- ADGM $9.34
- Technical
- Relative Strength Index (RSI)
- BCTX 44.63
- ADGM N/A
- Support Level
- BCTX $2.78
- ADGM N/A
- Resistance Level
- BCTX $3.16
- ADGM N/A
- Average True Range (ATR)
- BCTX 0.19
- ADGM 0.00
- MACD
- BCTX -0.01
- ADGM 0.00
- Stochastic Oscillator
- BCTX 40.24
- ADGM 0.00
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
About ADGM ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.